It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Here, we investigate radiomics-based characterization of tumor vascular and microenvironmental properties in an orthotopic rat brain tumor model measured using dynamic-contrast-enhanced (DCE) MRI. Thirty-two immune compromised-RNU rats implanted with human U-251N cancer cells were imaged using DCE-MRI (7Tesla, Dual-Gradient-Echo). The aim was to perform pharmacokinetic analysis using a nested model (NM) selection technique to classify brain regions according to vasculature properties considered as the source of truth. A two-dimensional convolutional-based radiomics analysis was performed on the raw-DCE-MRI of the rat brains to generate dynamic radiomics maps. The raw-DCE-MRI and respective radiomics maps were used to build 28 unsupervised Kohonen self-organizing-maps (K-SOMs). A Silhouette-Coefficient (SC), k-fold Nested-Cross-Validation (k-fold-NCV), and feature engineering analyses were performed on the K-SOMs’ feature spaces to quantify the distinction power of radiomics features compared to raw-DCE-MRI for classification of different Nested Models. Results showed that eight radiomics features outperformed respective raw-DCE-MRI in prediction of the three nested models. The average percent difference in SCs between radiomics features and raw-DCE-MRI was: 29.875% ± 12.922%, p < 0.001. This work establishes an important first step toward spatiotemporal characterization of brain regions using radiomics signatures, which is fundamental toward staging of tumors and evaluation of tumor response to different treatments.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Henry Ford Health, Department of Radiation Oncology, Detroit, USA (GRID:grid.239864.2) (ISNI:0000 0000 8523 7701); Michigan State University, Department of Radiology, East Lansing, USA (GRID:grid.17088.36) (ISNI:0000 0001 2150 1785); Michigan State University, Department of Osteopathic Medicine, East Lansing, USA (GRID:grid.17088.36) (ISNI:0000 0001 2150 1785); Oakland University, Department of Physics, Rochester, USA (GRID:grid.261277.7) (ISNI:0000 0001 2219 916X)
2 Henry Ford Health, Department of Radiation Oncology, Detroit, USA (GRID:grid.239864.2) (ISNI:0000 0000 8523 7701); Michigan State University, Department of Radiology, East Lansing, USA (GRID:grid.17088.36) (ISNI:0000 0001 2150 1785); Wayne State University, Department of Radiation Oncology, Detroit, USA (GRID:grid.254444.7) (ISNI:0000 0001 1456 7807)
3 Michigan State University, Department of Computer Science and Engineering, East Lansing, USA (GRID:grid.17088.36) (ISNI:0000 0001 2150 1785)
4 Michigan State University, Department of Radiology, East Lansing, USA (GRID:grid.17088.36) (ISNI:0000 0001 2150 1785); Henry Ford Health, Department of Neurosurgery, Detroit, USA (GRID:grid.239864.2) (ISNI:0000 0000 8523 7701)
5 Michigan State University, Department of Radiology, East Lansing, USA (GRID:grid.17088.36) (ISNI:0000 0001 2150 1785); Oakland University, Department of Physics, Rochester, USA (GRID:grid.261277.7) (ISNI:0000 0001 2219 916X); Henry Ford Health, Department of Neurosurgery, Detroit, USA (GRID:grid.239864.2) (ISNI:0000 0000 8523 7701); Henry Ford Health, Department of Neurology, Detroit, USA (GRID:grid.239864.2) (ISNI:0000 0000 8523 7701); Wayne State University, Department of Neurology, Detroit, USA (GRID:grid.254444.7) (ISNI:0000 0001 1456 7807)
6 Henry Ford Health, Department of Radiation Oncology, Detroit, USA (GRID:grid.239864.2) (ISNI:0000 0000 8523 7701); Oakland University, Department of Physics, Rochester, USA (GRID:grid.261277.7) (ISNI:0000 0001 2219 916X); Wayne State University, Department of Radiation Oncology, Detroit, USA (GRID:grid.254444.7) (ISNI:0000 0001 1456 7807)